Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 19,300 shares at $98.88 ($2.0M) on 2024-09-30, disclosed to the SEC on 2024-10-02.
Scheduled sale ($2.0M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.88 | 700 | $69K | 3.5% |
| 2 | $100.09 | 1,305 | $131K | 6.7% |
| 3 | $100.09 | 1,305 | $131K | 6.7% |
| 4 | $101.13 | 5,032 | $509K | 26.1% |
| 5 | $101.13 | 5,032 | $509K | 26.1% |
| 6 | $101.89 | 2,963 |
| $302K |
| 15.5% |
| 7 | $101.89 | 2,963 | $302K | 15.5% |
| Total | $101.14 avg | 19,300 | $2.0M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |